Weekly Glance for January 21st

What's new in optometry, week by week.


Something you may start hearing about: Decorin.

What is decorin?
Decorin is found at high levels in the corneal stroma. It regulates cell proliferation, survival, and has previously been shown to inhibit scar formation and neovascularization in the cornea.

Why do we care about this?
Because a research team published a study showing that a gel-like eye drop containing decorin was able to significantly reduce corneal scarring in mice with pseudomonas ulcers.

There's more...
Two weeks after this study was published, another study aimed at treating corneal scarring was published in Stem Cells Translational Medicine. It used a viscoelastic gel carrier to deliver mesenchymal stem cells to treat corneal scarring from chemical burns. Both studies show promising results in mouse models.  


Cool people recycle.

Johnson & Johnson launched a recycling program with TerraCycle in the UK. It's similar to the one Bausch + Lomb has in the US.


Does my statin medication help with my diabetic retinopathy?

Maybe. A new study published in JAMA Ophthalmology found that patients taking a statin had a reduced risk of diabetic retinopathy.

The study details:
The study included almost 38,000 Taiwanese patients between the years 1998-2013. All had type 2 diabetes and dyslipidemia and half of them took statins, the other half didn't. 

What did they find?
A couple of main points:
1. Patients that took a statin had a reduced risk of diabetic retinopathy and a lower need for invasive treatments (i.e vitrectomies, intravitreal injections).
2. The benefit increased as the statin intensity increased giving better LDL reduction.
This data complements the ACCORD study that found a similar effect.

How do statins help diabetic retinopathy?
Statins can improve endothelial function and they have anti-inflammatory, antioxidation, and antithrombotic effects. These effects seem to prevent the development of diabetic retinopathy.



The percentage of ophthalmologists that are burned out. (via)


The percentage of patients that would like to purchase contacts or glasses with their smartphone. (via)

25 million

The estimated number of Americans that experience daily pain. This new device aims to measure a patient's level of pain by looking at their pupils. 


The percentage of the US population that is myopic. Learn more about myopia management in this podcast.
Hey guys! 
Do any of you have a side hustle you're passionate about? I want to highlight you here! Reach out and share it with me!
Hope you have a great week!
Jackie Garlich
Editor & Founder // 20/20 Glance

Enjoy this email? Tell your friends to sign up here!
Have news or a comment to share?
Copyright © 2019 2020glance, All rights reserved.

Email Me // About // Update Profile // Unsubscribe